Drug recall · May 7, 2025
Medroxyprogesterone Acetate Injectable Suspension recall
Why: Severe thunderstorms caused transit delays of certain cold chain products that were shipped on 02-Apr-2025 and delivered after the 48-hours specified delivery time, on 07-Apr-2025 and 08-Apr-2025. The affected products may not have been stored at the recommended labeled storage conditions which may have impacted the safety, quality, identity, potency and purity of the product.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Medroxyprogesterone Acetate Injectable Suspension, USP, 150 mg / mL, 1 mL Single-Dose Vial, Rx only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, NDC 55150-0330-01
- Lots / codes
Lot #: 1MP24042, Exp 6/30/26
- Quantity
- 3
- Company
- Mckesson Medical-Surgical Inc. Corporate Office, Richmond, VA
- Distribution
- Distributed to Medical Facilities in MS and FL.
- Initiated
- April 25, 2025 · Voluntary: Firm initiated
- Classified
- May 1, 2025
- Reported
- May 7, 2025
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Medroxyprogesterone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.